ADAPTIVE-CONTROL OF ETOPOSIDE ADMINISTRATION - IMPACT OF INTERPATIENT PHARMACODYNAMIC VARIABILITY

被引：76

作者：

RATAIN, MJ

SCHILSKY, RL

CHOI, KE

GUARNIERI, C

GRIMMER, D

VOGELZANG, NJ

SENEKJIAN, E

LIEBNER, MA

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637

[2] UNIV CHICAGO,PRITZKER SCH MED,CLIN PHARMACOL CLIN 1,CHICAGO,IL 60637

[3] UNIV CHICAGO,PRITZKER SCH MED,DEPT OBSTET & GYNECOL,CHICAGO,IL 60637

来源：

关键词：

D O I：

10.1038/clpt.1989.22

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：226 / 233

页数：8

共 26 条

[1] HIGH-DOSE METHOTREXATE - A CRITICAL REAPPRAISAL
ACKLAND, SP
SCHILSKY, RL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) : 2017 - 2031
[2] ACKLAND SP, IN PRESS CLIN PHARM
[3] COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES
ALLEN, LM
CREAVEN, PJ
[J]. EUROPEAN JOURNAL OF CANCER, 1975, 11 (10) : 697 - 707
[4] BENNETT CL, 1987, CANCER RES, V47, P1952
[5] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF MITOMYCIN IN BIOLOGICAL-FLUIDS
CHOI, KE
SINKULE, JA
CROM, WR
THOMPSON, EI
EVANS, WE
[J]. JOURNAL OF CHROMATOGRAPHY, 1985, 345 (01): : 197 - 202
[6] CLARK PI, 1988, P AM ASSOC CANC RES, V29, P192
[7] DINCALCI M, 1986, CANCER RES, V46, P2566
[8] EGORIN MJ, 1986, CANCER RES, V46, P1513
[9] EGORIN MJ, 1984, CANCER RES, V44, P5432
[10] EGORIN MJ, 1987, CANCER RES, V47, P617